Overview
Citizens Petition
Sponsors
- Sustaining Partners
May 2012-
The Search for an Ideal Analgesic
June 2011-
Pharmacotherapy for Prescription Opioid Addiction
March 2011-
Advancing Safe Opioid Prescribing through Prescriber Training and Behavior Change
June 2010-
Payer Issues Related to Prescription Opioid Monitoring and Abuse
March 2010-
The role of Dentists in Preventing Opioid Abuse
July 2009-
Risk Evaluation and Mitigation Strategy for Prescription Opioids
April 2009-
Prescription Monitoring Research Update
November 2008-
Co-ingestion of Alcohol with Prescription Opioids
June 2008-
The Role of Urine Drug Monitoring in Pain Management
March 2008-
Sources of Diverted Prescription Opioids
September 2007-
Understanding the Types of Opioid Abusers
March 2007-
Responding to Signals of Opioid Abuse
November 2006-
Development of Abuse Deterrent Formulations
September 2006-
Best Practices in Opioid Risk Management
October 2005-
Opioid Abuse Resistance
March 2005-
Opioid Risk Management
TUFTS HEALTH CARE INSTITUTE PROGRAM ON OPIOID RISK MANAGEMENT-
Compendium


Tufts Health Care Institute Program on
Opioid Risk Management

The mission of the Tufts Health Care Institute Program on Opioid Risk Management is to address challenges in the development and utilization of opioid analgesics, by engaging a multidisciplinary group of stakeholders focused on optimizing the benefits of opioid for pain management, and minimizing their risks, including abuse and diversion.

March 27-28, 2008
Agenda

Welcome and Introductions
Nathaniel Katz, MD, MS, Presentation >>

Law Enforcement Primer
Presentation >>

Drug Diversion Diversion-Addressing the Problems in the Future
John J. Burke, Presentation >>

The Contributions of Qualitative Research Methods for Studying Rx Drug Diversion
James A. Inciardi, Ph.D., Presentation >>

Using PMP Data to Assess Prescription Opioid Diversion: Ohio’s Experience
Danna E. Droz, RPh, JD, Presentation >>

Prescription Monitoring to Address Drug Diversion
Grant M. Carrow, Ph.D., Presentation >>

FDA Expectations Regarding Assessment, Prevention, and Intervention of Prescription Opioid Abuse & Diversion
Michael Klein, Ph.D, Presentation >>

SAMHSA Initiatives to Address Diversion While Maintaining Opioid Access
Nicholas Reuter, Presentation >>

Epidemiology of Opioid Diversion
Nabarun Dasgupta Presentation >>

Concurrent Workgroup Breakouts

Group:  Standards for Supply Chain (Manufacturer to Pharmacy) Control of Prescription Opioid Diversion
Presentation >>

Group: Prevention, Interventions, and Solutions
Presentation >>

© 2012 Tufts Health Care Institute •   Boston, MA 02111 •   (617) 636-1000
Home